Speeckaert R - Search Results

1

Lapeere H, Speeckaert R, Baeck M, Dezfoulian B, Lambert J, Roquet-Gravy PP, Stockman A, White J, Castelijns F, Gutermuth J. Lapeere H, et al. Among authors: speeckaert r. Acta Clin Belg. 2024 Feb;79(1):62-74. doi: 10.1080/17843286.2023.2285576. Epub 2024 Jan 2. Acta Clin Belg. 2024. PMID: 37997950 Review.

2

Reference method for digital surface measurement of target lesions in vitiligo: a comparative analysis.

van Geel N, Vandendriessche D, Vandersichel E, De Schepper S, Grine L, Mertens L, Vandaele V, Spoelders F, Bekkenk M, Wolkerstorfer A, Prinsen CA, Speeckaert R. van Geel N, et al. Among authors: speeckaert r. Br J Dermatol. 2019 May;180(5):1198-1205. doi: 10.1111/bjd.17190. Epub 2018 Nov 13. Br J Dermatol. 2019. PMID: 30207606

3

A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response.

De Wolf K, Kruse V, Sundahl N, van Gele M, Chevolet I, Speeckaert R, Brochez L, Ost P. De Wolf K, et al. Among authors: speeckaert r. J Transl Med. 2017 Jan 31;15(1):21. doi: 10.1186/s12967-017-1123-x. J Transl Med. 2017. PMID: 28137295 Free PMC article.

4

Reliability and validity of the Vitiligo Signs of Activity Score (VSAS).

van Geel N, Passeron T, Wolkerstorfer A, Speeckaert R, Ezzedine K. van Geel N, et al. Among authors: speeckaert r. Br J Dermatol. 2020 Nov;183(5):883-890. doi: 10.1111/bjd.18950. Epub 2020 Mar 29. Br J Dermatol. 2020. PMID: 32064583 Free PMC article.

5

Development of a 3D pigmented skin model to evaluate RNAi-induced depigmentation.

Van Gele M, Geusens B, Speeckaert R, Dynoodt P, Vanhoecke B, Van Den Bossche K, Lambert J. Van Gele M, et al. Among authors: speeckaert r. Exp Dermatol. 2011 Sep;20(9):773-5. doi: 10.1111/j.1600-0625.2011.01319.x. Epub 2011 Jun 24. Exp Dermatol. 2011. PMID: 21707757

6

Editorial: Immunology of Vitiligo.

Seneschal J, Harris JE, Le Poole IC, Passeron T, Speeckaert R, Boniface K. Seneschal J, et al. Among authors: speeckaert r. Front Immunol. 2021 Jun 24;12:711080. doi: 10.3389/fimmu.2021.711080. eCollection 2021. Front Immunol. 2021. PMID: 34249018 Free PMC article. No abstract available.

7

Tumor necrosis factor receptors: biology and therapeutic potential in kidney diseases.

Speeckaert MM, Speeckaert R, Laute M, Vanholder R, Delanghe JR. Speeckaert MM, et al. Among authors: speeckaert r. Am J Nephrol. 2012;36(3):261-70. doi: 10.1159/000342333. Epub 2012 Sep 5. Am J Nephrol. 2012. PMID: 22965073 Free article. Review.

8

Pelger-Huët anomaly: a critical review of the literature.

Speeckaert MM, Verhelst C, Koch A, Speeckaert R, Lacquet F. Speeckaert MM, et al. Among authors: speeckaert r. Acta Haematol. 2009;121(4):202-6. doi: 10.1159/000220333. Epub 2009 May 26. Acta Haematol. 2009. PMID: 19468205 Review.

9

Autoimmunity in Segmental Vitiligo.

Speeckaert R, Lambert J, Bulat V, Belpaire A, Speeckaert M, van Geel N. Speeckaert R, et al. Among authors: speeckaert m. Front Immunol. 2020 Oct 27;11:568447. doi: 10.3389/fimmu.2020.568447. eCollection 2020. Front Immunol. 2020. PMID: 33193342 Free PMC article. Review.

10

The role of interleukin-17A in the pathogenesis of kidney diseases.

Cortvrindt C, Speeckaert R, Moerman A, Delanghe JR, Speeckaert MM. Cortvrindt C, et al. Among authors: speeckaert r, speeckaert mm. Pathology. 2017 Apr;49(3):247-258. doi: 10.1016/j.pathol.2017.01.003. Epub 2017 Mar 11. Pathology. 2017. PMID: 28291548 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

148 results

Search Page